China Medical Device Executive Leadership Training

Currently, China spends $640 billion on healthcare every year, and represents the most significant growth market in the world for the medical device industry. The market presents tremendous opportunities for U.S. companies. One challenge is that China’s approval process for imported medical devices is very slow.

The U.S. Trade and Development Agency is hosting a training for 24 senior officials from China’s Food and Drug Administration (CFDA) and the curriculum will feature global best practices on approving imported medical devices. The CFDA delegation will meet with U.S. government agencies, medical device industry associations, and U.S. companies interested in accessing this market in China.

As part of the Training Program, USTDA will host a Business Briefing for U.S. companies in Washington, DC.

WHY YOUR BUSINESS SHOULD ATTEND

• Learn about the needs and goals of China’s medical devices regulatory environment

• Connect with key decision-makers in China

• Create potential business opportunities

• Meet with key officials from China’s FDA

TOPICS OF DISCUSSION WILL INCLUDE

• Building a Cooperative Regulatory Environment in China

• Fostering Innovation

• The “21st Century Cures Act”

• Clinical Trials Requirements

• Medical Device Regulatory Issues China

• Unique Device Identification (UDI)

• Harmonization and Classification

PHM International, Inc. is organizing this program on behalf of USTDA. To learn more about sponsorship opportunities for U.S. companies, please contact Drew Arvary of PHM International at DrewA@phmintl.com.

For more information on the business briefing and to register, please contact Hank Kearney at hankk@phmintl.com or visit: www.phmintl.com/china-FDA.